(Q50506365)

English

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.

scientific article published on 24 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

author name string

M M Mueller

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

H Bialleck

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

B Bomke

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

S Brauninger

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

C Varga

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

C Seidl

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

E Seifried

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

T Tonn

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

publication date

24 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

104

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

46-54

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Severe events in donors after allogeneic hematopoietic stem cell donation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Safety of bone marrow stem cell donation: a review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Stem cell donation--what advice can be given to the donor?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Epoetin-associated pure red cell aplasia: past, present, and future considerations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

When biotech proteins go off-patent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01632.X

21 January 2018

Identifiers

10.1111/J.1423-0410.2012.01632.X

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22827736

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50506365&oldid=831408525"